New research refutes the theory that cannabis is a ‘gateway drug’.
Researchers found no significant increase in the rates of psychosis-related diagnoses in states which have introduced legalisation.
Cannabis-based medicines led to a ‘substantial improvement’ in symptoms of BPD, also known as emotionally unstable personality disorder (EUPD).
Researchers found a reduction of 26% in pharmacy-based distribution of codeine in states where cannabis was legal.
The project hopes to show that cannabis would be cost-effective if prescribed through the NHS for chronic pain.
Regular consumers reported fewer health issues and used less prescription medications.
New studies highlight the effects of cannabis in those living with depression, childhood epilepsy and inflammatory bowel disease (IBD).
UK company, Chanelle McCoy Health, has been granted ethics approval in Australia for a clinical trial investigating the effect of its synthetic CBD formulation on sleep....
The findings have led to calls for more patient-doctor communication around its use in medical care.
The findings help us understand the therapeutic effects of THC at the molecular level.